Page 7 - Medication Control News Today

HIWU Relaunches Anonymous Whistleblower Platforms in Partnership with RealResponse; Platforms Now Accepting Tips for both ADMC and Racetrack Safety Programs

HISA Anti-Doping and Medication Control Program to Relaunch May 22, 2023, Under Enforcement of HIWU

Mofebutazone is an analogue of phenylbutazone exhibiting a non-steroidal anti-inflammatory (NSAID) mechanism of action.

With safety concerns at the forefront head of the 148th running of The Preakness Stakes, veterinarians and gaming officials discussed protocols in place to protect riders and the horses.

A federal judge denied a motion for an injunction by the National HBPA to prevent HISA's Anti-Doping and Medication Control program from going into effect May 22.

Following a successful launch on March 27, the Horseracing Integrity & Welfare Unit (HIWU) is planning to resume enforcement of the Horseracing Integrity and Safety Authority’s (HISA) Anti-Doping and Medication Control (ADMC) Program on May 22.

HISA is conducting its own review of the circumstances surrounding the deaths of horses at Churchill Downs this spring.

Saffie Joseph Jr. was suspended indefinitely by Churchill Downs Incorporated after two horses under his supervision suddenly died following races in the Kentucky Derby.

Horse racing’s new antidoping and medication control program has stumbled out of the starting gate. Its been delayed multiple times for nearly a year amid lawsuits by those opposing the

Horse racings new antidoping and medication control program has stumbled out of the starting gate, delayed multiple times for nearly a year amid lawsuits by those opposing the new rules and frustration from those eager for national uniform standards in the sport.